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ABSTRACT
HT1080 cells stably expressing green ¯uorescent
protein (GFP) linked to a 3¢ terminal AU-rich element
(ARE) proved to be a convenient system to study
the dynamics of mRNA stability, as changes in
mRNA levels are re¯ected in increased or decreased
¯uorescence intensity. This study examined
whether mRNA stability can be regulated by small
interfering RNAs (siRNAs) targeted to AU-binding
proteins (AUBPs), which in turn should reveal their
intrinsic role as stabilizers or destabilizers of ARE-
mRNAs. Indeed, siRNAs targeting HuR or BRF1
decreased or increased ¯uorescence, respectively.
This effect was abolished if cells were treated with
both siRNAs, thus indicating antagonistic control of
ARE-mRNA stability. Unexpectedly, downregulation
of all four AUF1 isoforms by targeting common
exons did not affect ¯uorescence whereas selective
downregulation of p40AUF1/p45AUF1 strongly increased
¯uorescence by stabilizing the GFP±ARE reporter
mRNA. This observation was fully con®rmed by the
®nding that only selective reduction of p40AUF1/
p45AUF1 induced the production of GM-CSF, an endo-
genous target of AUF1. These data suggest that the
relative levels of individual isoforms, rather than the
absolute amount of AUF1, determine the net mRNA
stability of ARE-containing transcripts, consistent
with the differing ARE-binding capacities of the
isoforms.
INTRODUCTION
Regulation of mRNA turnover is a key mechanism determin-
ing the intracellular abundance of transcripts, thus contribut-
ing to the controlled production of the encoded gene products
(1±3). So far, the best characterized cis-elements mediating
control of mRNA stability are the AU-rich elements (ARE)
contained in the 3¢ untranslated region (3¢UTR) of cytokines,
growth factors and proto-oncogenes (4,5). Presence of an ARE
induces rapid shortening of the poly-A tail followed by
exosomal degradation of the mRNA body (6±8). Transcripts
containing an ARE usually exhibit rapid decay in resting cells,
but are readily stabilized upon exposure to exogenous signals.
Importantly, defective ARE function causing increased tran-
script stability has been reported to be a pathogenic factor in
human malignancies (9±11), experimental tumors (12) and
in¯ammatory disorders (13,14).
Several proteins binding to the ARE, AU-rich element
binding proteins (AUBPs) have been identi®ed and shown to
exert a de®ned role in ARE-mRNA turnover. HuR, a member
of the embryonic lethal abnormal vision (ELAV) RNA
binding protein family has been shown to stabilize ARE-
mRNAs (15,16). Two closely related proteins also containing
RNA recognition motifs (RRM), TIA-1 (T-cell internal
antigen-1) and TIAR (TIA-1-related protein), bind the ARE
and act as translational silencers (17). Tristetraprolin (TTP,
zfp-36) the prototype of a family of zinc-®nger proteins of the
unusual Cys-Cys-Cys-His (CCCH) class promotes degrad-
ation of tumor necrosis factor a (TNFa) (18,19), granulocyte-
macrophage colony stimulating factor (GM-CSF) (20) and
interleukin-3 (IL-3) mRNA (21). Butyrate response factor 1
(BRF1, zfp-36l1), a second member of the same class of zinc
®nger proteins, has been identi®ed using functional genetic
screening (22) and was shown to mediate rapid decay of
various cytokine mRNAs, including IL-3, IL-6, GM-CSF and
TNFa (23). Finally, AUF1 was ®rst identi®ed as a promoter of
rapid ARE-mRNA decay in extracts of K562 cells (24).
However, upon puri®cation and cloning, the recombinant
protein lacked decay promoting activity (25). The analysis of
AUF1 has been further complicated by the existence of four
isoforms that arise by differential splicing (26). This family of
proteins distinguishes a 37 kDa (p37AUF1) core protein, a
40 kDa protein (p40AUF1) containing an N-terminal 19 amino
acid insertion (exon 2), a 42 kDa protein (p42AUF1) exhibiting
a C-terminal 49 amino acids insertion (exon 7), and a 45 kDa
protein (p45AUF1) with insertions of both exon 2 and exon 7.
Presence or absence of these alternatively spliced exons
confers distinct biological properties to individual AUF1
isoforms. Presence of exon 7 not only affects nucleo-
cytoplasmic distribution (27,28), but also blocks ubiquitin-
ation of p42AUF1 and p45AUF1 (29). In contrast, the lack of
exon 7 targets p37AUF1 and p40AUF1 to the ubiquitin±
proteasome pathway, which results in rapid decay of ARE-
mRNAs (30,31). Importantly, absence of exon 2 in 37AUF1 and
p42AUF1 is associated with high af®nity binding of these
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isoforms (26). In addition to its role in ARE-mRNA turnover,
AUF1 has been proposed to be involved in multiple cellular
processes such as telomere maintenance (32) and transcrip-
tional activation (33). The fact that AUF1 was identi®ed to be
a component of the a-globin mRNA stability complex (34)
and to participate in mRNA decay directed by the c-fos major
coding determinant (35) points to a more general function of
this protein in mRNA turnover. With respect to ARE-mRNA
turnover, the role of AUF1 has been extensively studied, but
results were con¯icting. Increased expression of AUF1 has
been associated with rapid ARE-mRNA decay in peripheral
blood mononuclear cells (PBMC) (36,37), smooth muscle
cells (38) and monocytes (39). These data, together with the
®nding that forced expression of p37AUF1 and p42AUF1
antagonized stabilization of ARE-mRNAs accompanying
hemin-induced erythroid differentiation of K562 cells (40)
argue for an intrinsic destabilizing activity of AUF1.
However, overexpression of all four AUF1 isoforms in
NIH3T3 cells stabilized ARE-containing transcripts (41). It
has not been resolved whether these disparities were due to the
different cell types examined or changes in experimental
conditions. Analysis of AUF1 knockout mice or studies using
small interfering RNAs (siRNAs) targeted to AUF1 should
help to clarify these issues.
The present study examined whether single or combined
treatment of cells with siRNAs targeting HuR, BRF1 and
AUF1 would affect ARE-mediated mRNA turnover. Our data
indicate that BRF1 and HuR control ARE-mRNA stability in
an antagonistic fashion. Furthermore, we present evidence that
effects of AUF1 on ARE-containing transcripts depend on the
expression level of individual AUF1 isoforms.
MATERIALS AND METHODS
Cell culture and transfection
The previously described HT1080-derived reporter cell line
HTwt16 (21) was cultured in Iscove's Modi®ed Dulbecco
Medium containing 10% fetal calf serum (FCS), 50 mM
2-mercaptoethanol, 2 mM glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin at 37°C/7% CO2. In addition,
NIH 3T3 cells stably expressing the GFP±ARE (3T3GFP±
ARE) were generated and cultured as described above.
For transfections, 1.5 3 105 cells were plated per well of a
6-well plate and cultured overnight. Thereafter, siRNAs were
transfected at a ®nal concentration of 240 nM in the presence
of serum free medium (OptiMEM, Invitrogen) using
Oligofectamine (Invitrogen) as the carrier. Analyses were
performed 48±72 h after transfection.
Oligoribonucleotides
The following 19mer oligoribonucleotide duplexes containing
a 2-nt deoxythymidine overhang at each 3¢ end were
purchased from Xeragon. BRF1, 5¢ CAA GAU GCU CAA
CUA UAG U; HuR (oligo A), 5¢ UAA AGU AGC AGG ACA
CAG C; HuR (oligo B), 5¢ CAC GCU GAA CGG CUU GAG
G (42); AUF1 (exon 1), 5¢ GAU UGA CGC CAG UAA GAA
C; AUF1 (exon 2/oligo A), 5¢ ACG AGG AGG AUG AAG
GCC A (the ®rst 16 nt are located in exon 1, the last 3 nt in
exon 2); AUF1 (exon 2/oligo B), 5¢ GCA GCG ACG GCA
CAG CGG G; AUF1 (exon 3), 5¢ GAU CCU AUC ACA GGG
CGA U; AUF1 (exon 7), 5¢ CUG GAA CCA GGG AUA UAG
U; b-globin, 5¢ CAA GAA AGU GCU CGG UGC C.
Sequences were derived from the human sequences of HuR
mRNA (accession number BC003376), BRF1 mRNA (acces-
sion number NM_007564), AUF1 mRNA (accession number
NM_031370) and b-globin mRNA (accession number
V00497.1). Blast search was performed on all the sequences
to avoid cross-reaction with other genes.
Flow cytometry
FACS analysis of 1±2 3 104 cells was performed using a
FACScan (Becton Dickinson) and the Cellquest software.
GFP ¯uorescence was excited at 488 nm and emission was
measured at 510 nm. To analyze the difference in ¯uorescence
between medium and siRNA treated cells, Kolmogorow±
Smirnow statistics calculating the greatest difference (D) in
¯uorescence between these two treatments were performed.
The mean 6 standard deviation (SD) of D for 4±9 independent
experiments was calculated and Student's t-test comparing D
of b-globin and speci®c siRNA-treated cells was performed.
Northern blot analysis
To analyze mRNA levels in cells treated with speci®c siRNAs,
total RNA was harvested 72 h after transfection using Trizolâ
(Invitrogen). Total RNA (10±15 mg) was resolved on 1%
agarose±formaldehyde gels, which were subsequently blotted
onto Hybond-N+ membranes (Amersham) using 203 SSC. To
detect HuR, ®lters were hybridized in the presence of 50%
formamide (43) using a [a-32P]GTP-labeled SP6 transcribed
probe spanning nt 121±488 of the murine HuR cDNA
(accession number NM_010485). To detect BRF1, control
b-actin and G3PDH, PCR fragments of the respective cDNAs
(BRF1, nt 524±1019, accession number X99404; G3PDH,
nt 589±1246, accession number M33197; murine b-actin,
nt 554±815, accession number X03765) were labelled with
[a-32P]dCTP using Klenow enzyme (New England Biolabs)
and the gene speci®c 3¢ primers. Filters were hybridized
overnight at 65°C in 0.5 M sodium phosphate buffer pH 7.2
containing 1% BSA (Fraction V, Sigma), 7% SDS and 5 mM
EDTA, and subsequently washed at 55°C each in 23 SSC/
0.2% SDS and 0.23 SSC/0.2% SDS.
To analyze mRNA stability of the GFP±ARE reporter, cells
were treated 72 h after transfection with 5 mg/ml of
actinomycin D. Cytoplasmic RNA was harvested at the
indicated time-points (44) and northern blot analysis per-
formed using an SP6 transcribed [a-32P]GTP-labeled probe
spanning a XbaI±EcoRI fragment containing the murine IL-3
3¢UTR as described.
Signal intensities were quanti®ed using a Personal
Molecular Imagerâ FX (Bio-Rad) and the Quantity OneÔ
software (Bio-Rad). To normalize for loading differences,
signal intensities were normalized to the b-actin or G3PDH
control.
Western blot analysis
Western blot analysis was performed as recently described
(21). Brie¯y, 30±50 mg of total cell lysates in RIPA buffer
(BRF1 and AUF1) or 15 mg of cytoplasmic cell lysate (HuR),
prepared with the NE-PERâ nuclear cytoplasmic extraction
reagents (Pierce), were resolved on 4±20% gradient poly-
acrylamide gels (Anamed Electrophorese GmbH) and blotted
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onto Immobilon-P (Millipore) membranes. To detect BRF1, a
polyclonal antibody was generated in rabbits immunized with
a C-terminal BRF1 peptide (SDSPTLDNSRRLPIFSRLSI-
SDD; Neosystem) covalently linked to KLH. Antibodies were
subsequently af®nity puri®ed using the BRF1 peptides
employed in immunization. Monoclonal mouse-anti human
HuR (Santa Cruz), polyclonal rabbit-anti human AUF1
(Upstate Biotechnology) and monoclonal mouse-anti bovine
a-tubulin antibodies (Molecular Probes) served to detect the
respective genes. An alkaline phosphatase-coupled goat-anti-
rabbit IgG (Southern Biotechnology Associates Inc.) or a
horseradish-peroxidase-coupled goat-anti-mouse IgG (DAKO)
were used as secondary antibodies. Development was per-
formed using CDP-Star (Roche) or ECL Advance (Amersham),
respectively. For quanti®cation, autoradiographs were scanned
and analyzed by densitometry using the Quantity Oneâ
software (Bio-Rad).
Detection of GM-CSF by ELISA
Supernatants of triplicate cultures treated with medium or
individual siRNA were harvested 72 h after transfection. GM-
CSF was determined by ELISA (Pharmingen) according to the
manufacturers instructions.
RESULTS
SiRNA targeting HuR and BRF1
We recently showed that siRNA targeting BRF1 increased
mRNA stability of a GFP±ARE reporter and, concomitantly,
¯uorescence of transfected cells by FACS. Indeed, these
siRNAs allowed distinction between cells with two wild-type
BRF1 alleles from cells exhibiting a heterozygous inactivation
of BRF1, solely based on the extent of the ¯uorescence shift
(22). These data encouraged us to extend this approach to
further AUBPs, arguing that if changes in GFP±ARE
transcript stability are faithfully re¯ected in altered ¯uores-
cence intensity, this approach will enable the assessment of
ARE-mRNA turnover rates in live cells without requiring the
use of transcriptional inhibitors. As exempli®ed in Figure 1,
downregulation of AUBPs stabilizing or destabilizing ARE-
mRNAs will decrease or increase ¯uorescence intensity,
respectively.
First, we investigated HuR, an AUBP known to stabilize
ARE-mRNAs (15,16). A siRNA targeting HuR was designed
that reduced HuR mRNA levels to 40% of medium or b-globin
siRNA treated controls. By comparison, treatment of cells
with BRF1 siRNA alone or in combination with b-globin or
HuR siRNAs reduced BRF1 mRNA levels to 25% of controls
(Fig. 2A). An additional HuR siRNA that had recently been
described by others (42) reduced HuR protein levels to 60% of
controls by western blot (Fig. 2B). Ef®cient inhibition of
BRF1 by siRNA was also established in western blots using a
polyclonal anti-BRF1 antibody generated in rabbits immun-
ized with a C-terminal peptide of BRF1. Speci®c recognition
of BRF1 by this antibody was con®rmed by the absence of the
signal in mutant slowC cells, which lack BRF1 expression
compared to parental Htwt16 cells, which express wild-type
BRF1 (22) (Fig. 2B).
Next, we determined by FACS whether siRNA treatment
affected GFP expression. The results of two independent
experiments are shown in Figure 2C. For quanti®cation, the
greatest difference (D) in ¯uorescence between the curves
obtained from cells treated with medium or siRNA was
calculated using Kolmogorow±Smirnov statistics (Table 1). In
experiment 1, no signi®cant differences were observed
between cells transfected with medium or a non-speci®c
b-globin control siRNA (Fig. 2C, panel A). However,
transfection of HuR siRNA decreased ¯uorescence (panel B)
and BRF1siRNA increased ¯uorescence as previously repor-
ted (panel D) (22). To evaluate whether HuR siRNA might
antagonize the stabilizing effect of BRF1 siRNA, cells were
treated with combinations of siRNAs. Combined treatment
with HuR or BRF1 and a non-speci®c b-globin siRNA led to
the same shift in ¯uorescence as treatment with HuR or BRF1
siRNA alone (panel C and E). In contrast, combined treatment
with BRF1 and HuR siRNA abolished the effects of the single
Figure 1. Reporter system employed to reveal effects of decreased AUBP
expression on ARE-mRNA stability. HT1080 cells stably expressing a GFP±
ARE reporter (HTwt16) are transfected with siRNA targeting AUBP.
Decreasing the level of an AUBP that stabilizes ARE-mRNAs should result
in decreased ¯uorescence by FACS. In contrast, downregulation of an AUBP
that destabilizes ARE-mRNAs should result in increased ¯uorescence.
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siRNAs (panel F). We veri®ed these ®ndings with a second
HuR siRNA (Fig. 2C, experiment 2). Again, HuR siRNA
decreased ¯uorescence of transfected cells compared to
b-globin siRNA-treated control cells (panel G) and
annihilated the increase in ¯uorescence observed in cells
treated solely with BRF1 siRNA (panels H and I).
Figure 2. HuR and BRF1 siRNA have opposing effects on ¯uorescence and GFP±ARE mRNA stability in Htwt16 cells. (A) Northern blot analysis of HuR
and BRF1 expression in Htwt16 cells treated for 72 h with control b-globin, HuR (oligo A), BRF1 siRNA or their combinations. (B) Western blots of 15 mg
of cytoplasmic and 30 mg of total cell lysate to analyze cells treated with HuR (oligo B) or BRF1 siRNA. As control for the speci®city of the anti-BRF1 anti-
body, absence of the BRF1 signal in slowC cells lacking BRF1 expression is shown in comparison to Htwt16 cells, which express wild-type BRF1. (C)
FACS analysis of cells treated for 72 h. In experiment 1 (A±F) the shaded areas represent medium and the overlays siRNA-treated cells; HuR (oligo A) was
employed in panels B and F. In experiment 2 (G±I) the shaded curves represent cells treated with b-globin control and the overlays represent cells treated
with speci®c BRF1 and/or HuR (oligo B) siRNA. (D) To evaluate the effects of siRNA on GFP±ARE mRNA stability, cells were exposed to actinomycin D
for the indicated time-points 72 h after transfection of medium, b-globin control, BRF1 and/or HuR (oligo A) siRNA. Values were normalized to the b-actin
control. (E) Quanti®cation of the mean 6 SEM of at least three independent experiments is shown and the half-life (T1/2) of the GFP±ARE reporter for each
individual treatment is indicated.
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To evaluate whether changes in ¯uorescence were accom-
panied by altered mRNA stability of the GFP±ARE reporter,
actinomycin D chase experiments were performed. The results
of a representative experiment are shown in Figure 2D and
quanti®cation of at least three independent experiments for
each treatment is exhibited in Figure 2E. Cells treated with
HuR siRNA exhibited reduced GFP±ARE mRNA levels and a
slightly accelerated decay that was re¯ected in a decrease of
the GFP±ARE half-life (t1/2 = 1.2 6 0.2 h) compared to
controls (t1/2 = 1.6 6 0.2 h). The stabilization exerted by BRF1
siRNA (t1/2 = 3.0 6 0.6 h) was reversed by combined
treatment with HuR siRNA (t1/2 = 1.8 6 0.4 h). In all
actinomycin D chase experiments performed, we observed the
decay of the GFP±ARE mRNA reporter to be fastest during
the ®rst hour of treatment. Actinomycin D has been shown to
itself stabilize ARE-mRNAs (45), an effect that may be
responsible for the observed impediment of decay at later time
points. Together, changes in ¯uorescence intensity in cells
treated with BRF1, HuR and combinations of these two
siRNAs were qualitatively re¯ected in altered decay rates of
the GFP±ARE reporter mRNA.
SiRNA targeting AUF1
The role of AUF1 in ARE-mediated mRNA decay is
complicated by the existence of four isoforms and both
destabilizing and stabilizing effects have been reported
(40,41). To differentially decrease selected AUF1 isoforms
we targeted siRNA to exons 1 and 3, which are common to all
four isoforms, to exon 2, which is contained in p40AUF1 and
p45AUF1, and to exon 7, which is present in p42AUF1 and
p45AUF1 (Fig. 3A). First, to evaluate whether the selected
siRNA would speci®cally reduce the targeted isoforms we
analyzed their distribution by western blot and quanti®ed the
respective bands by densitometry (Fig. 3B). In all experiments
performed, we observed a non-speci®c band (marked by an
asterisk) at ~55 kDa whose signal intensity correlated to the
a-tubulin loading control as determined by densitometry (data
not shown). The p37 and p45 isoforms were clearly distin-
guished in control cells (lanes 1 and 2). However, p40AUF1,
which is highly abundant in these cells, resolved as a very
broad band obscuring simultaneous detection of the weakly
expressed p42AUF1. As expected, both siRNAs targeting exons
1 and 3 decreased expression of all four isoforms (lanes 3 and
6). Two independent oligoribonucleotide duplexes targeting
exon 2 of AUF1 reduced only expression of p40AUF1, the most
abundant isoform in this cell line, and p45AUF1 (lanes 4 and 5).
In contrast, expression of p37AUF1 was comparable to medium
or b-globin siRNA-treated controls. Of note, the low abundant
p42 isoform became visible only after selective removal of
p40AUF1, in cells treated with exon 2-speci®c siRNA. Finally,
siRNA targeting exon 7 speci®cally reduced p45AUF1. The
concomitant decrease of p42AUF1 could not be analyzed (lane
7), due to the reasons mentioned above. In conclusion, the
AUF1 siRNA employed allowed selective and ef®cient
inhibition of the targeted isoforms, with p45AUF1 being
reduced to 10±27% of controls by the different siRNA.
Next, we investigated how the different AUF1 siRNA
affected ¯uorescence of transfected cells by FACS. Figure 4A
shows a representative experiment and quanti®cation is
exhibited in Table 2. Decreasing the expression of all four
isoforms by targeting exon 1 or 3 did not signi®cantly alter
¯uorescence compared to b-globin siRNA-treated controls
(panels B and E). Downregulation of both p42AUF1 and p45AUF1
led in some experiments to a slight, not consistently observed
and statistically not signi®cant, decrease of ¯uorescence
compared to controls (panel F and Table 2). Together, these
data might indicate that AUF1 does not affect expression of the
GFP±ARE reporter in this cell line. However, we observed a
signi®cant increase of ¯uorescence in cells exhibiting reduced
p40AUF1 and p45AUF1 expression after treatment with two
independent exon 2-speci®c oligoribonucleotide duplexes
(panels C and D). To substantiate these ®ndings we performed
a titration experiment, treating cells with 240±1.92 nM of the
different AUF1 siRNA employed. Whereas siRNA targeting
exons 1, 3 or 7 did not increase ¯uorescence of transfected cells
at any of the concentrations tested, both siRNA targeting exon 2
increased ¯uorescence, with a minimal effect still being
observed at 9.6 nM (data not shown).
Actinomycin D chase experiments (Fig. 4B) revealed that
cells exhibiting an increased ¯uorescence due to selective
reduction of p40AUF1/p45AUF1 indeed showed a slower decay
rate of the GFP±ARE reporter compared to b-globin siRNA-
or medium-treated controls. The half-life of the GFP±ARE
reporter mRNA in cells treated with AUF1 siRNA targeting
exon 2 varied between individual experiments, but a con-
sistent increase was observed compared to controls. The
reduced decay rate of the GFP±ARE mRNA in cells thus
treated was re¯ected in an accordingly increased steady-state
level of the reporter, which was, however, 15±20% higher than
expected. This discrepancy between the predicted and the
observed increase was within the variation of the experiment.
In contrast, cells exhibiting reduced levels of all four AUF1
isoforms or selectively of p42AUF1/p45AUF1 showed decay
rates of the reporter that were within the range of the controls.
In addition, NIH 3T3 cells stably expressing the GFP±ARE
reporter also exhibited only an increased ¯uorescence if
treated with AUF1 (exon 2a), but not AUF1 (exon 3) siRNA
(data not shown).
Effects of HuR, BRF1 and AUF1 siRNA on endogenous
GM-CSF expression
To validate these data we wished to investigate whether these
siRNAs in¯uenced expression of a physiological endogenous
Table 1. Treatment of Htwt16 cells with HuR siRNA decreases
¯uorescence, an effect that is reversed upon combined treatment with
BRF1 siRNA
siRNA treatment na Fluorescenceb DKolmogorow±Smirnowc Pd
mean 6 SD
b-globin 13 no effect 0.07 6 0.04
HuR 9 decreased 0.23 6 0.08 <0.05
HuR + b-globin 4 decreased 0.24 6 0.23 <0.05
BRF1 9 increased 0.31 6 0.12 <0.05
BRF1 + b-globin 5 increased 0.29 6 0.11 <0.05
HuR + BRF1 5 no effect 0.07 6 0.03 = 0.9
aNumber of experiments.
bEffect on ¯uorescence of medium compared to siRNA-treated cells. For
statistical analysis only HuR (oligo A) was taken into consideration.
cGreatest distance (D) between curves obtained from medium- and siRNA-
treated cells.
dStudent's t-test comparing D of cells treated with control b-globin and
speci®c siRNA.
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target gene. A recent cDNA microarray analysis had revealed
that HT1080 cells lacking wild-type BRF1 (22) expressed at
least six-fold higher GM-CSF mRNA and protein levels
compared to cells with two intact BRF1 alleles, thus
identifying GM-CSF as a BRF1 target gene (unpublished
data). Therefore, HT1080 cells were treated for 72 h with the
different siRNAs and secreted GM-CSF was subsequently
determined by ELISA. Treatment with BRF1 siRNA in-
creased GM-CSF production, an effect that was reduced upon
simultaneous addition of HuR but not of b-globin siRNA
(Fig. 5A). Extending this study to AUF1, a known regulator of
GM-CSF expression (46), we found an even more powerful
effect than with BRF1 siRNA. Of note, only selective
reduction of p40AUF1/p45AUF1 increased GM-CSF expression,
whereas reduction of all four isoforms or p42AUF1/p45AUF1
again had no effect (Fig. 5B). The increase in GM-CSF
expression in cells treated with AUF1 (exon 2a) siRNA was
partially reversed if cells were simultaneously treated with
HuR siRNA (Fig. 5C). Therefore, not only do the relative
levels of stabilizing and destabilizing AUBPs regulate
expression of GM-CSF but, surprisingly, also the relative
levels of individual AUF1 isoforms.
DISCUSSION
The present study was designed to evaluate siRNA targeting
AUBPs in the investigation of ARE-mRNA turnover. This
seemed to be a timely objective as, with the exception of TTP
(47), no AUBP knockout mice models have been reported.
Results gained from loss-of-function experiments are needed
to validate data previously obtained by overexpression of
AUBPs. This is of particular importance because these
experiments did not provide unifying conclusions (see below).
Figure 3. Exon-speci®c targeting of AUF1 allows selective reduction of speci®c AUF1 isoforms in Htwt16 cells. (A) Schematic drawing of the mRNAs
coding for the different AUF1 isoforms and the localization of the siRNA employed. Location of the RRMs and the glutamine rich (Q) stretch are indicated.
The siRNA AUF1 (exon 2/oligo A) marked by an asterisk targets 16 bp of exon 1 and 3 bp of exon 2. (B) Two independent western blots of cells treated for
72 h with AUF1 siRNA targeting exon 1 (lanes 3), exon 2 (lanes 4 and 5), exon 3 (lanes 6) and exon 7 (lanes 7). The asterisk marks a non-speci®c band at
~55 kDa that was observed in all experiments performed, and whose signal intensity correlated to the a-tubulin loading control in individual samples.
Quantitative analysis of experiment 2 is shown in the table.
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Indeed, treatment of Htwt16 cells with siRNA targeting
HuR, a protein known to stabilize ARE-mRNAs (15,16)
decreased ¯uorescence intensity and promoted decay of the
GFP±ARE-mRNA reporter, thus con®rming HuR to be a
stabilizer of ARE-mRNAs. BRF1 siRNA induced the
expected increase in ¯uorescence intensity and stabilized the
GFP±ARE reporter, effects that were nulli®ed in cells treated
with a combination of HuR and BRF1 siRNAs. Inactive
siRNAs have been claimed to compete with active siRNAs in
a sequence-independent manner (48). However, non-speci®c
effects were ruled out in our experiments, showing that cells
treated with a combination of BRF1 and control b-globin
siRNA exhibited the same shift in ¯uorescence as cells treated
solely with BRF1 siRNA. Thus, we concluded that HuR and
BRF1 control mRNA stability of the GFP±ARE reporter in an
antagonistic fashion, presumably by competing for the ARE.
Figure 4. Selective downregulation of p40AUF1/p45AUF1 increases ¯uorescence and stabilizes the GFP±ARE reporter in Htwt16 cells. (A) FACS analysis of
cells treated for 72 h with medium or siRNA as indicated. (B) To evaluate the effects of siRNA on GFP±ARE mRNA stability, cells were exposed to
actinomycin D for the indicated time-points 72 h after transfection of siRNA.
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Experiments revealing that BRF1 and HuR also exerted
opposing effects on expression of GM-CSF, an endogenous
BRF1 target gene recently identi®ed by cDNA microarray,
further validated our ®ndings.
In contrast to BRF1 and HuR, the role of AUF1 in ARE-
mRNA turnover has not been fully clari®ed. Conclusions, of
whether this protein acts as a stabilizer or destabilizer of ARE-
mRNAs, are based on indirect evidence associating AUF1
abundance with ARE-mRNA stability (36,38,39,49) and on
experiments using AUF1 overexpression, which provided
ambiguous results. In NIH 3T3 cells, all four isoforms
stabilized ARE-mRNAs (41). Other studies, however, showed
that both p37AUF1 and p40AUF1 promoted decay in several cell
lines investigated, including NIH 3T3 (50). Also, in K562
cells forced expression of AUF1 antagonized stabilization of
ARE-mRNAs (40). The reasons for these discrepancies are not
clear. Short of performing a gene knockout experiment, exon-
speci®c targeting of AUF1 by siRNA might provide a more
physiologic approach to functionally dissect this gene. At ®rst
sight, our ®nding that two different siRNAs ef®ciently
inhibiting expression of all four AUF1 isoforms did not
exert an effect on cellular ¯uorescence or mRNA stability at
any of the concentrations tested would argue that, at least in
HT1080 cells, AUF1 is not involved in steady-state control of
ARE-mRNA turnover. However, this possibility was rejected
because the decrease of p40AUF1/p45AUF1 in cells treated with
exon 2-speci®c siRNA strongly induced cellular ¯uorescence
and stabilized the GFP±ARE reporter mRNA. This seems to
be mainly due to reduction of the most abundant p40 isoform
rather than to the decrease in p45AUF1 because downregulation
of p42AUF1 together with p45AUF1 did not signi®cantly affect
¯uorescence of transfected cells. We wish to stress that the
AUF1 siRNA employed had the same effect on GM-CSF, a
gene known to be controlled by AUF1 (46). Again, down-
regulation of all four isoforms had no effect, whereas selective
reduction of p40AUF1 and p45AUF1 strongly stimulated GM-
CSF production. Based on these results, one might draw the
conclusion that p40AUF1, like BRF1, acts as a destabilizer of
ARE-mRNAs. However, we would like to offer an alternative
explanation.
The four AUF1 isoforms differ considerably in their ARE-
binding af®nities in vitro, with the rank order of p37>p42>
p45>p40 (26) and the two isoforms with the highest binding
af®nity exert the most profound effect on ARE-mRNA
stability (40,41). Thus, we propose that in HT1080 cells the
highly abundant yet low-af®nity p40AUF1 competes with
p37AUF1 and p42AUF1for ARE-binding. After selective down-
regulation of p40AUF1, p37AUF1 and p42AUF1 gain access to the
ARE and stabilize transcripts. This model does not exclude
that post-transcriptional modi®cations of AUF1 might play an
additional role, as the af®nity of p40AUF1 for the ARE has been
shown to be affected by phosphorylation (51±53). Our
proposition that alterations in ARE-mRNA stability might
be induced by changes in the relative rather than the absolute
levels of AUF1 isoforms would explain why the uniform
reduction of all four isoforms had no effect. A key factor may
well be the ratio of p37AUF1 and possibly p42AUF1 to p40AUF1.
This notion is supported by two previous observations. First,
the decreased stability of the b-adrenergic receptor mRNA in
the failing compared to normal human heart has been
Table 2. Exon speci®c targeting of AUF1 reveals downregulation of p40AUF1/p45AUF1 to increase ¯uorescence of transfected cells
siRNA treatment Isoforms targeted na Fluorescenceb DKolmogorow±Smirnow
c
mean 6 SD
Pd
b-globin 7 no effect 0.09 6 0.04
AUF1 exon 1 p37, p40, p42, p45 4 no effect 0.09 6 0.05 = 1
AUF1 exon 2 (oligo A) p40, p45 7 increased 0.46 6 0.09 <0.05
AUF1 exon 2 (oligo B) p40, p45 4 increased 0.29 6 0.09 <0.05
AUF1 exon 3 p37, p40, p42, p45 4 no effect 0.1 6 0.08 = 0.9
AUF1 exon 7 p42, p45 4 no effect 0.12 6 0.03 = 0.2
aNumber of experiments.
bEffect on ¯uorescence of medium compared to siRNA-treated cells (Fig. 4A).
cGreatest distance (D) between curves obtained from medium and siRNA-treated cells.
dStudent's t-test comparing D of cells treated with control b-globin and speci®c siRNA.
Figure 5. Downregulation of p40AUF1/p45AUF1 increases GM-CSF secretion of transfected Htwt16 cells. Secreted GM-CSF was measured by ELISA in the
culture supernatant of cells treated for 72 h with BRF1 and HuR (oligo A) siRNA (A), AUF1 siRNA (B) and AUF1 (exon 2a) and HuR (oligo A) siRNA (C).
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associated with an increased expression of both p40AUF1 and
p45AUF1 (38). Second, differential expression of AUF1
isoforms accompanied the decreased half-life of GM-CSF
mRNA in neonatal compared to adult PBMC (36,37). Both
p37AUF1 and p40AUF1 were decreased in the latter, whereas
expression of p42AUF1 was comparable in neonatal and adult
PBMC. If our model is correct, it would follow that mRNA
splicing might ultimately in¯uence ARE-mRNA stability by
determining the relative levels of individual AUF1 isoforms.
The fact that simultaneous targeting of HuR and p40AUF1/
p45AUF1 partially cancelled the effect of solely targeting
p40AUF1/p45AUF1 clearly indicates that the relative levels of the
individual AUF1 isoforms can only be one determinant of
ARE-mRNA stability. We propose that the quantity of all
stabilizing (HuR) and destabilizing AUBPs (TTP, BRF1,
BRF2), together with the relative amount of the individual
AUF1 isoforms, determines the net stability of ARE-
containing transcripts in a balanced fashion. Thus, silencing
a single destabilizing factor will tip the balance towards
increased stabilization despite the fact that other ARE-
destabilizing factors may still be present. In return, decreasing
the expression of any stabilizing factor will favor destabiliz-
ation despite the potential presence of additional stabilizing
AUBPs.
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